OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · 1994 · 11 citations · 0 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic Nuclear MedicineRadionuclide TherapyPost-therapy ImagingRadioiodine TherapyThyroid CancerThyroid ImagingThyroid ScintigraphyThyroid Uptake StudiesIodine-123 ScintigraphyIodine-131 ScintigraphyIodine-131 Therapy ImagingMetastatic Thyroid Tissue DetectionPost-therapy Thyroid ScanPost-therapy Uptake EvaluationRadioiodine Uptake MeasurementRadionuclide Thyroid Scintigraphy
Whole body scintigraphy is recommended following ablative I-131 therapy to assess residual iodine-avid tissue, including metastasis in patients with DTC. Some controversy exists regarding the optimum time for performing the post-ablative study. A study performed as early as 2 days post-therapy would be desirable since patients could be scanned prior to discharge from the hospital.